Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017)

Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Preferred Dividend Payments came in at $5000.0 in Q1 2017, up 141.67% year-on-year from $2069.0 in Q1 2016, and down 58.33% quarter-over-quarter from $12000.0 in Q4 2016.

Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017) Analysis & Trends

Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $5000.0 for Q1 2017.

  • On a quarterly basis, Preferred Dividend Payments rose 141.67% year-over-year to $5000.0 in Q1 2017; TTM through Dec 2017 was $5000.0, a 80.0% decrease from a year earlier, with the FY2017 full-year figure at $5000.0, down 89.8% from the prior year.
  • Preferred Dividend Payments retreated to $5000.0 in Q1 2017 per VRDN's latest filing, from $12000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $13000.0 in Q3 2016 and bottomed at -$12000.0 in Q1 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Viridian Therapeutics, Inc.\DE 229.55 Mn 229.55 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2017 5,000.00
Dec 31, 2016 12,000.00
Sep 30, 2016 13,000.00
Jun 30, 2016 12,000.00
Mar 31, 2016 -12,000.00